Neonatal fluid and electrolytes profile effect on amphotericin B associated nephrotoxicity in neonatal tertiary care unit of Karachi-Pakistan

References

• Mantadakis E, Pana ZD, Zaoutis T. Candidemia in children: epidemiology, prevention and management. Mycoses. 2018;61(9):614–622.
   PubMed Web of Science ®Google Scholar
• Pana ZD, Roilides E, Warris A, et al. Epidemiology of invasive fungal disease in children. J Pediatric Infect Dis Soc. 2017;6(suppl_1):S3–S11.
   PubMedGoogle Scholar
• Benjamin DK, Stoll BJ, Gantz MG, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010;126(4):e865–e73.
   PubMed Web of Science ®Google Scholar
• Aliaga S, Clark RH, Laughon M, et al. Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics. 2014;133(2):236–242.
   PubMed Web of Science ®Google Scholar
• Kumar S, Kalam K, Ali S, et al. Frequency, clinical presentation and microbiological spectrum of candidemiain a tertiary care center in Karachi, Pakistan. Age. 2014;35:13.27.
   Google Scholar
• Farooqi J, Jabeen K, Saeed N, et al., Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility. J Med Microbiol. 2013;62(2):259.
   PubMedGoogle Scholar
• Ariff S, Saleem AF, Soofi SB, et al., Clinical spectrum and outcomes of neonatal candidiasis in a tertiary care hospital in Karachi, Pakistan. J Infect Developing Countries. 2011;5(3):216–223.
   Google Scholar
• Beck-Sague CM, Azimi P, Fonseca SN, et al. Bloodstream infections in neonatal intensive care unit patients: results of a multicenter study. Pediatr Infect Dis J. 1994;13(12):1110–1116.
   PubMed Web of Science ®Google Scholar
• Weese-Mayer DE, Fondriest DW, Brouillette RT, et al. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J. 1987;6(2):190–196.
   PubMed Web of Science ®Google Scholar
• Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 1998;17(6):504–508.
   PubMed Web of Science ®Google Scholar
• Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in neonatal intensive care unit patients. Pediatr Infect Dis J. 2000;19(4):319–324.
   PubMed Web of Science ®Google Scholar
• Carey AJ, Saiman L, Polin RA. Hospital-acquired infections in the NICU: epidemiology for the new millennium. Clin Perinatol. 2008;35(1):223–249.
   PubMed Web of Science ®Google Scholar
• Howell A, Isaacs D, Halliday R, et al. Oral nystatin prophylaxis and neonatal fungal infections. Arch Dis Childhood-Fetal Neonatal Ed. 2009;94(6):F429–F33.
   PubMed Web of Science ®Google Scholar
• Adams-Chapman I, Bann CM, Das A, et al. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr. 2013;163(4):961–967. e3.
   PubMed Web of Science ®Google Scholar
• Clerihew L, McGuire W. 2012. Antifungal therapy for newborn infants with invasive fungal infection. Cochrane Database Syst Rev. (6). DOI:10.1002/14651858.CD003953.pub3.
   PubMed Web of Science ®Google Scholar
• Zhao L, Jiang J, Zhu Z, et al. Lysine enhances the effect of amphotericin B against Candida albicans in vitro. Acta Biochim Biophys Sin (Shanghai). 2016;48(2):182–193.
   PubMed Web of Science ®Google Scholar
• Autmizguine J, Guptill JT, Cohen-Wolkowiez M, et al. Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications. Drugs. 2014;74(8):891–909.
   PubMed Web of Science ®Google Scholar
• Montagna MT, Coretti C, Lovero G, et al., Diagnostic performance of 1→ 3-β-d-glucan in neonatal and pediatric patients with candidemia. Int J Mol Sci. 2011;12(9):5871–5877.
   PubMed Web of Science ®Google Scholar
• Greenberg RG, Benjamin DK Jr, Gantz MG, et al. Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis. J Pediatr. 2012;161(2):264–269. e2.
   PubMed Web of Science ®Google Scholar
• Frattarelli DA, Reed MD, Giacoia GP, et al. Antifungals in systemic neonatal candidiasis. Drugs. 2004;64(9):949–968.
   PubMed Web of Science ®Google Scholar
• Baley JE, Meyers C, Kliegman RM, et al., Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr. 1990;116(5):791–797.
   PubMed Web of Science ®Google Scholar
• Karimzadeh I, Heydari M, Ramzi M, et al. Frequency and associated factors of amphotericin b nephrotoxicity in hospitalized patients in hematology-oncology wards in the Southwest of Iran. Nephro-urol Mon. 2016;8(5). DOI:10.5812/numonthly.39581.
   PubMedGoogle Scholar
• Karimzadeh I, Khalili H, Farsaei S, et al. Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity. Eur J Clin Pharmacol. 2013;69(7):1351–1368.
   PubMed Web of Science ®Google Scholar
• Karimzadeh I, Farsaei S, Khalili H, et al., Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity? Expert Opin Drug Saf. 2012;11(6):969–983.
   PubMed Web of Science ®Google Scholar
• Mayer J, Doubek M, Doubek J, et al. Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study. J Infect Dis. 2002;186(3):379–388.
   PubMed Web of Science ®Google Scholar
• Bernardo JF, Murakami S, Branch RA, et al. Potassium depletion potentiates amphotericin-B-lnduced toxicity to renal tubules. Nephron. 1995;70(2):235–241.
   PubMed Web of Science ®Google Scholar
• Holler B, Omar SA, Farid MD, et al., Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants. Pediatrics. 2004;113(6):e608–e16.
   PubMed Web of Science ®Google Scholar
• Agras PI, Tarcan A, Baskin E, et al. Acute renal failure in the neonatal period. Ren Fail. 2004;26(3):305–309.
   PubMed Web of Science ®Google Scholar
• Bolat F, Comert S, Bolat G, et al. Acute kidney injury in a single neonatal intensive care unit in Turkey. World J Pediatr. 2013;9(4):323–329.
   PubMed Web of Science ®Google Scholar
• Dhondup T, Qian Q. Acid-base and electrolyte disorders in patients with and without chronic kidney disease: an update. Kidney Dis. 2017;3(4):136–148.
   Google Scholar
• Berenguer J, Buck M, Witebsky F, et al. Lysis—Centrifugation blood cultures in the detection of tissue-proven invasive candidiasis disseminated versus single-organ infection. Diagn Microbiol Infect Dis. 1993;17(2):103–109.
   PubMed Web of Science ®Google Scholar
• Jetton JG, Askenazi DJ. Update on acute kidney injury in the neonate. Curr Opin Pediatr. 2012;24(2):191.
   PubMed Web of Science ®Google Scholar
• Linder N, Klinger G, Shalit I, et al. Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations. J Antimicrob Chemother. 2003;52(4):663–667.
   PubMed Web of Science ®Google Scholar
• Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med. 1994;331(20):1325–1330.
   PubMed Web of Science ®Google Scholar
• Sultan F, Khan A. Infectious diseases in Pakistan: a clear and present danger. Lancet. 2013;381(9884):2138–2140.
   PubMed Web of Science ®Google Scholar
• Jafar TH, Haaland BA, Rahman A, et al. Non-communicable diseases and injuries in Pakistan: strategic priorities. Lancet. 2013;381(9885):2281–2290.
   PubMed Web of Science ®Google Scholar
• Jabeen K, Farooqi J, Mirza S, et al., Serious fungal infections in Pakistan. Eur J Clin Microbiol Infect Dis. 2017;36(6):949–956.
   PubMed Web of Science ®Google Scholar
• Llanos A, Cieza J, Bernardo J, et al. Effect of salt supplementation on amphotericin B nephrotoxicity. Kidney Int. 1991;40(2):302–308.
   PubMed Web of Science ®Google Scholar
• Girmenia C, Cimino G, Di Cristofano F, et al. Effects of hydration with salt repletion on renal toxicity of conventional amphotericin B empirical therapy: a prospective study in patients with hematological malignancies. Support Care Cancer. 2005;13(12):987–992.
   PubMed Web of Science ®Google Scholar
• Che D, Zhou H, Li T, et al. Duration and intensity of fluconazole for prophylaxis in preterm neonates: a meta-analysis of randomized controlled trials. BMC Infect Dis. 2016;16(1):312.
   PubMedGoogle Scholar